ARNA Financial Facts

Other: 660K
Net loss per share allocable to common stockholders, basic: -0.1
See Full Income Statement

Accumulated deficit: -1.29B
Common stock: 24K
See Full Balance Sheet

Arena Pharmaceuticals, Inc. (ARNA) Earnings

  |   Expand Research on ARNA
Next EPS Date 8/3/15 *Est. EPS Growth Rate +16.7% *Last Qtr.
Average EPS % Beat Rate +47.3% Revenue Growth Rate +80.9% *Last Qtr.
Average % Move 1-Wk after EPS -1.2% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/11/15 Q115 -$0.10-$0.14 +$0.04$12.3M$10.56M N/A Details
3/2/15 Q414 -$0.15-$0.12 -$0.03$9.2M$10.36M N/A Details
11/3/14 Q314 -$0.05-$0.12 +$0.07$8.2M$10.9M N/A Details
8/1/14 Q214 $0.03-$0.11 +$0.14$12.8M$9.81M N/A Details
5/12/14 Q114 -$0.12-$0.10 -$0.02$6.8M$7.98M N/A Details
2/27/14 Q413 -$0.11-$0.11 $0.00$6.2M$7M N/A Details
11/7/13 Q313 -$0.08-$0.12 +$0.04$3.6M$5.3M N/A Details
8/1/13 Q213 $0.18$0.15 +$0.03$68.9M$57.3M N/A Details